Immunotherapy for Ovarian Cancer: Adjuvant, Combination, and Neoadjuvant.

Yang, Chang; Xia, Bai-Rong; Zhang, Zhao-Cong; Zhang, Yong-Jian; Lou, Ge; Jin, Wei-Lin

Yang, Chang; Xia, Bai-Rong; Zhang, Zhao-Cong; Zhang, Yong-Jian; Lou, Ge; Jin, Wei-Lin.

Afiliação

Yang C; Department of Gynecology Oncology, Harbin Medical University Cancer Hospital, Harbin, China.
Xia BR; Department of Gynecology Oncology, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, China.
Zhang ZC; Department of Gynecology Oncology, Harbin Medical University Cancer Hospital, Harbin, China.
Zhang YJ; Department of Gynecology Oncology, Harbin Medical University Cancer Hospital, Harbin, China.
Lou G; Department of Gynecology Oncology, Harbin Medical University Cancer Hospital, Harbin, China.
Jin WL; Department of Instrument Science and Engineering, Institute of Nano Biomedicine and Engineering, Shanghai Engineering Center for Intelligent Diagnosis and Treatment Instrument, Key Laboratory for Thin Film and Microfabrication Technology of Ministry of Education, School of Electronic Information and

Front Immunol ; 11: 577869, 2020.

Article em En | MEDLINE | ID: mdl-33123161

Assuntos

Imunoterapia; Terapia Neoadjuvante; Neoplasias Ovarianas/terapia; Animais; Protocolos de Quimioterapia Combinada Antineoplásica/uso terapêutico; Vacinas Anticâncer/uso terapêutico; Quimioterapia Adjuvante; Feminino; Humanos; Inibidores de Checkpoint Imunológico/uso terapêutico; Imunoterapia/efeitos adversos; Imunoterapia Adotiva; Terapia Neoadjuvante/efeitos adversos; Terapia Viral Oncolítica; Neoplasias Ovarianas/imunologia; Neoplasias Ovarianas/mortalidade; Neoplasias Ovarianas/patologia; Resultado do Tratamento; Microambiente Tumoral

Palavras-chave

combination therapy; immune checkpoint inhibitors (ICI); immunotherapy; ovarian cancer; tumor microenvironment

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / Terapia Neoadjuvante / Imunoterapia Tipo de estudo: Prognostic_studies Limite: Animals / Female / Humans Idioma: En Revista: Front Immunol Ano de publicação: 2020 Tipo de documento: Article País de afiliação: China País de publicação: Suíça

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google